We are very excited to participate in this year's #IOSummit. Meet our CEO,
@SarahM_Jenna & discuss how we can help you de-risk drug development & clinical trials with our product that’s transforming outdated approaches to drug discovery in oncology.
French newspaper @lemondefr highlighted the work done by our team in partnership with the @chumontreal.
To read the full story click on the link 👇
https://t.co/v4EjB8HGk9
MIMs team is growing! We are looking for a talented Director of Business Development.
🙋♀️🙋♂️💻 Apply today and send your resume to [email protected]!
➡️ https://t.co/mc3T7p2pi0
We are excited to attend Intelligent Health 2022 Virtually.
Connect with our CEO Sarah Jenna to learn more about our SaaS platform.
Link: https://t.co/18WxZ0G0b7
#clinicaltrial#translational#oncology
Derisk oncology drug development & clinical trials with a software-in-the-cloud for target, indication prioritization & biomarker discovery.
📆 Schedule a Demo today: https://t.co/EZ72l4Y6P8
#clinicalttrials#Oncology#SaaS#Biomarkerdiscovery#drugdiiscovery
Our CTO @CamusMickael was featured in a podcast, where he talks about his journey & MIMs with @PsGauthier. Discover how he went from being an AI expert working for the European Space Agency for the Galileo project to a serial entrepreneur.
Watch it 📽️https://t.co/T3NvnZtXEF
With MIMs, life scientists can now independently harness the power of systems biology, AI, & their own deep human knowledge and experience in cancer biology to push the boundaries of innovation & drug discovery.
➡️ See MIMs in action for yourself: https://t.co/xtxwtgpZBn
#DYK MIMs’ #augmentedintelligence platform can identify 30 to 200 genetic interactors of a drug target or focus genes in minutes?
Learn more: https://t.co/xtxwtgH2Dn
16,000 patients across > 200 cancer types. With MIMs, classify patients into subgroups, ID molecular & clinical characteristics, predict responses to therapies, & identify therapeutic targets and biomarkers.
🤝Book a demo: https://t.co/EZ72l5fHGG
🗓️ https://t.co/hGYoJSpB5s
Venez regarder le podcast de Mémoire Digitale où notre CTO et cofondateur @CamusMickael a été invité dans leur segment d’Innovation. Mickaël parle de son parcours professionnel et de MIMs avec @PsGauthier.
📽️📽️ https://t.co/T3NvnZtXEF
🎙️🔊 https://t.co/TXvjrCzbdL
MIMs is proud to be part of Precision Medicine World Conference @PMWC 2022. Come and meet our CEO @SarahM_Jenna on June 30th Track 7 at 11h45 AM PST during her presentation on our latest technologies at the “AI and Data Sciences Showcase”.
#PMWC22#AI#datascience
Congratulations to our NEW SOLUTION LEAD, Audrey Lemaçon ! Proud to have her lead the solution team.
Félicitations à notre NOUVELLE RESPONSABLE DE SOLUTION, Audrey Lemaçon ! Fiers de l'avoir à la tête de l'équipe de solutions.
#womenlead#womenintech#womeninstem#proud
Last Day at #BIO2022 virtually. If you have not meet with us yet, here is where you can contact us.
Click below to sent us a meeting request in the BIO partnering system! https://t.co/M4bjA7V46f
Book a virtual meeting with us
https://t.co/hGYoJSHcu2
What a great decision to launch our new product for indication prioritization & biomarker discovery at #ASCO22! We are thrilled with the response and interest! We've got demos booked, many leads to follow up on, & we're off to #BIO to keep spreading the word!
#clinicaltrials
Come see our poster presentation today from 8-12 ! Poster board #115. If you want to discuss further please meet us at our booth IH20! #asco#Oncology#ASCO22
Notre PDG @SarahM_Jenna a participé a un panel de discussion sur "Qu'est ce que cela veut dire #voirGrand" dans le domaine de la technologie lors de la conference #visionPDG !